Hemostatic system in early respiratory distress syndrome: reduced fibrinolytic state?

Area of Science:

• Neonatal Medicine
• Hematology
• Pulmonology

Background:

• Systemic clotting and fibrinolysis activation is noted in advanced respiratory distress syndrome (RDS) in preterm infants.
• Limited data exists on hemostatic status during the early stages of RDS.
• Understanding early hemostatic changes is crucial for timely intervention and management.

Purpose of the Study:

• To investigate hemostatic parameters in preterm infants within the first six hours of life.
• To compare hemostatic profiles between infants who develop RDS and those who do not.
• To identify early markers of hemostatic dysfunction in neonatal respiratory distress.

Main Methods:

• Prospective study of preterm infants using standardized protocols.
• Measurement of multiple hemostatic parameters including fibrinogen, protein C, protein S, and D-dimer.
• Analysis of plasminogen activator inhibitor and von Willebrand factor antigen levels.

Main Results:

• Plasma fibrinogen and other key clotting factors remained within normal limits in infants who developed RDS.
• Significantly lower D-dimer levels were observed within six hours of life in infants who later developed RDS.
• Elevated plasminogen activator inhibitor and von Willebrand factor antigen levels were found in infants who developed RDS.

Conclusions:

• Disseminated intravascular coagulation is not a prominent feature in the early stages of RDS.
• Reduced D-dimer and increased plasminogen activator inhibitor and von Willebrand factor may indicate early fibrinolytic system abnormalities.
• Further research is needed to elucidate the pathogenic significance of these early hemostatic changes in RDS.